Skip to main content

Advertisement

SpringerLink
Log in

How to treat aortic graft infection? With a special emphasis on xeno-pericardial aortic tube grafts

  • SPECIAL EDITION
  • Controversies in Surgery for Thoracic Aorta
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Infection of a vascular prosthesis or endovascular stent-graft is probably the most serious complication that may occur after implantation and dramatically affects the patient’s outcome. The most common etiology of graft and/or prosthetic valve infection is usually wound-related infection, followed by seeding from distant infection sites (lung, urinary tract). Surgical treatment is almost always required but even after surgery, morbidity can be significant. Operative procedure must be tailored according to the individual patient and to the experience of the surgical team. Complete resection of the infected foreign material with débridement of the surrounding tissue gives most probably the best results. Orthotopic reconstruction is the best option for all thoracic and thoraco-abdominal pathologies and the use of coated prostheses, industrially fabricated bio-conduits, homografts or self-made vascular tubes from xenopericardial tissue has to be discussed from case to case. In some exceptional situations, endovascular stent-graft can be performed as bridging to a more complete treatment if general condition of the patient has to be stabilized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Berger P, Vaartjes I, Moll FL, De Borst GJ, Blankensteijn JD, Bots ML. Cumulative incidence of graft infection after primary prosthetic aortic reconstruction in the endovascular era. Eur J Vasc Endovasc Surg. 2015;49:581–5.

    Article  CAS  PubMed  Google Scholar 

  2. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47:264–9.

    Article  PubMed  Google Scholar 

  3. O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44(1):38–45.

    Article  PubMed  Google Scholar 

  4. Cernohorsky P, Reijnen MM, Tielliu IF, van Sterkenburg SM, van den Dungen JJ, Zeebregts CJ. The relevance of aortic endograft prosthetic infection. J Vasc Surg. 2011;54(2):327–33.

    Article  PubMed  Google Scholar 

  5. Lyons OT, Patel AS, Saha P, Clough RE, Price N, Taylor PR. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg. 2013;46(3):306–13.

    Article  CAS  PubMed  Google Scholar 

  6. Greaves NS, Katsogridakis E, Faris B, Murray D. Prophylactic antibiotics for percutaneous endovascular procedures. Eur J Clin Microbiol Infect Dis. 2017;36:597–601.

    Article  CAS  PubMed  Google Scholar 

  7. Carrel T, Schmidli J. Management of vascular graft and endoprosthetic infection of the thoracic and thoraco-abdominal aorta. Multimed Man Cardiothorac Surg. 2011. doi:10.1510/mmcts.2010.004705.

    Article  PubMed  Google Scholar 

  8. Lyons OT, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of aortic graft infection: a case definition by the management of aortic graft infection collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52:758–63.

    Article  CAS  PubMed  Google Scholar 

  9. Hargrove WC, Edmunds LH. Management of infected thoracic aortic prosthetic grafts. Ann Thorac Surg. 1984;37:72–7.

    Article  PubMed  Google Scholar 

  10. Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg. 1999;67:1990–3.

    Article  CAS  PubMed  Google Scholar 

  11. Fatima J, Duncan AA, de Grandis E, Oderich GS, Kalra M, Gloviczki P, et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg. 2013;58(2):371–9.

    Article  PubMed  Google Scholar 

  12. LeMaire SA, Coselli JS. Options for managing infected ascending aortic grafts. J Thorac Cardiovasc Surg. 2007;134:839–43.

    Article  PubMed  Google Scholar 

  13. O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44:38–45.

    Article  PubMed  Google Scholar 

  14. Nakajima N, Masuda M, Ichinose M, Ando M. A new method for the treatment of graft infection in the thoracic aorta: in situ preservation. Ann Thorac Surg. 1999;67:1994–6.

    Article  CAS  PubMed  Google Scholar 

  15. Tossios P, Karatzopoulos A, Tsagakis K, Sapalidis K, Grosomanidis V, Kalogera A, Kouskouras K, Foroulis CN, Anastasiadis K. Treatment of infected thoracic aortic prosthetic grafts with the in situ preservation strategy: a review of its history, surgical technique, and results. Heart Lung Circ. 2014;23:24–31.

    Article  PubMed  Google Scholar 

  16. Umminger J, Krueger H, Beckmann E, Kaufeld T, Fleissner F, Haverich A, Shrestha M, Martens A. Management of early graft infections in the ascending aorta and aortic arch: a comparison between graft replacement and graft preservation techniques. Eur J Cardiothorac Surg. 2016;50:660–7.

    Article  PubMed  Google Scholar 

  17. Chervu A1, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg. 1991;14:521–4 (discussion 524–5).

    Article  CAS  PubMed  Google Scholar 

  18. Oderich GS, Bower TC, Hofer J, Kalra M, Duncan AA, Wilson JW, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg. 2011;53:99–106, 7e1–7 (discussion 7).

    Article  PubMed  Google Scholar 

  19. Pupka A, Skora J, Janczak D, Plonek T, Marczak J, Szydelko T. In situ revascularisation with silver-coated polyester prostheses and arterial homografts in patients with aortic graft infection—a prospective, comparative, single-centre study. Eur J Vasc Endovasc Surg. 2011;41:61–7.

    Article  CAS  PubMed  Google Scholar 

  20. Goëau-Brissonière O, Leport C, Bacourt F, Lebrault C, Comte R, Pechère JC. Prevention of vascular graft infection by rifampicin bonding to a gelatin-sealed dacron graft. Ann Vasc Surg. 1999;5:408–12.

    Article  Google Scholar 

  21. Zegelman M1, Guenther G, Waliszewski M, Pukacki F, Stanisic MG, Piquet P, Passon M, Halloul Z, Tautenhahn J, Claey L, Agostinho C, Simici D, Doebrich D, Mueller C, Balzer K. Results from the International Silver Graft Registry for high-risk patients treated with a metallic-silver impregnated vascular graft. Vascular. 2013;21:137–47.

    Article  PubMed  Google Scholar 

  22. Carrel TP, Berdat P, Englberger L, Eckstein F, Immer F, Seiler C, Kipfer B. Schmidli J. Aortic root replacement with a new stentless aortic valve xenograft conduit: preliminary hemodynamic and clinical results. J Heart Valve Dis. 2003;12:752–7.

    PubMed  Google Scholar 

  23. Siniawski H, Lehmkuhl H, Weng Y, Pasic M, Yankah C, Hoffmann M, Behnke I, Hetzer R. Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg. 2003;75:803–8.

    Article  PubMed  Google Scholar 

  24. Carrel TP, Schoenhoff FS, Schmidli J, Stalder M, Eckstein FS, Englberger L. Deleterious outcome of no-react-treated stentless valved conduits after aortic root replacement: why were warnings ignored? J Thorac Cardiovasc Surg. 2008;136:52–7.

    Article  PubMed  Google Scholar 

  25. Reineke DC, Kaya A, Heinisch PP, Oezdemir B, Winkler B, Huber C, Heijmen RH, Morshuis W, Carrel TP, Englberger L. Long-term follow-up after implantation of the Shelhigh® No-React® complete biological aortic valved conduit. Eur J Cardiothorac Surg. 2016;50:98–104.

    Article  PubMed  Google Scholar 

  26. Calderon E, Spina A, Camurri N, Bellieni L, Bentini C, Pugliese P. Early failure of Shelhigh bioconduit in aortic position: an underestimated drawback. Berlin: Fifth Biennal Meeting of the Society of Heart Valve Disease; 2009.

  27. Guenther SP, Reichelt A, Peterss S, Luehr M, Bagaev E, Hagl C, Pichlmaier MA, Khaladj N. Root replacement for graft infection using an all-biologic xenopericardial conduit. J Heart Valve Dis. 2016;25:440–7.

    PubMed  Google Scholar 

  28. Guihaire J, Kloeckner M, Deleuze P. Exclusion of complex paraannular aortic abscess with the freestyle xenograft. Ann Thorac Surg. 2016;102:e373–5.

    Article  Google Scholar 

  29. Schneider AW, Hazekamp MG, Versteegh MI, Bruggemans EF, Holman ER, Klautz RJ, Braun J. Stentless bioprostheses: a versatile and durable solution in extensive aortic valve endocarditis. Eur J Cardiothorac Surg. 2016;49:1699–704.

    Article  PubMed  Google Scholar 

  30. Bahnini A, Ruotolo C, Koskas F, Kieffer E. In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months’ follow-up. J Vasc Surg. 1991;14:98–102.

    Article  CAS  PubMed  Google Scholar 

  31. Chiesa R, Astore D, Piccolo G, Melissano G, Jannello A, Frigerio D, et al. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg. 1998;12:457–62.

    Article  CAS  PubMed  Google Scholar 

  32. Zhou W, Lin PH, Bush RL, Terramani TT, Matsuura JH, Cox M, et al. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections a multi-institutional experience. Tex Heart Inst J 2006;33:14–8.

  33. Vogt PR, Turina MI. Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts. Ann Thorac Surg. 1999;67:1986–9.

    Article  CAS  PubMed  Google Scholar 

  34. Minga Lowampa E, Holemans C, Stiennon L, Van Damme H, Defraigne JO. Late fate of cryopreserved arterial allografts. Eur J Vasc Endovasc Surg. 2016;52:696–702.

    Article  CAS  PubMed  Google Scholar 

  35. Czerny M, von Allmen R, Opfermann P, Sodeck G, Dick F, Stellmes A, et al. Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg. 2011;92:1657–62.

    Article  PubMed  Google Scholar 

  36. Oda T, Minatoya K, Kobayashi J, Okita Y, Akashi H, Tanaka H, Kawaharada N, Saiki Y, Kuniyoshi Y, Nishimura K. Prosthetic vascular graft infection through a median sternotomy: a multicentre review. Interact Cardiovasc Thorac Surg. 2015;20:701–6.

    Article  PubMed  Google Scholar 

  37. Samoukovic G, Bernier PL, Lachapelle K.Successful. Treatment of infected ascending aortic prosthesis by omental wrapping without graft removal. Ann Thorac Surg. 2008;86:287–9.

    Article  PubMed  Google Scholar 

  38. Krabatsch I, Hetzer R. Infected ascending aortic prosthesis: successful treatment by thoracic transposition of the greater omentum. Eur J Cardio-thorac Surg. 1995;9:223–5.

    Article  CAS  Google Scholar 

  39. Luciani N, Lapenna E, De Bonis M, Possati GF. Mediastinitis following graft replacement of the ascending aorta: conservative approach by omental transposition. Eur J Cardiothorac Surg. 2001;20:418–20.

    Article  CAS  PubMed  Google Scholar 

  40. Fujii T, Watanabe Y. Multidisciplinary treatment approach for prosthetic vascular graft infection in the thoracic aortic area. Ann Thorac Cardiovasc Surg. 2015;21:418–27.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Inoue H, Iguro Y, Yamamoto H, Ueno M, Higashi A, Tao K, et al. Palliative stent-graft insertion followed by an allograft replacement for an infected and ruptured aortic aneurysm. Ann Thorac Cardiovasc Surg. 2009;15:261–4.

    PubMed  Google Scholar 

  42. Ito T, Kurimoto Y, Kawaharada N, Koyanagi T, Hashiguchi H, Yamashita A. Endovascular stent-grafting of anastomotic pseudoaneurysms following thoracic aortic surgery. Gen Thorac Cardiovasc Surg. 2009;57:528–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic for Cardiovascular Surgery, University Hospital Bern, University of Bern, 3010, Bern, Switzerland

    Thierry Carrel, Lars Englberger & Jürg Schmidli

Authors
  1. Thierry Carrel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lars Englberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jürg Schmidli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thierry Carrel.

Ethics declarations

Conflict of interest

All authors have declared that no conflict of interest exists.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carrel, T., Englberger, L. & Schmidli, J. How to treat aortic graft infection? With a special emphasis on xeno-pericardial aortic tube grafts. Gen Thorac Cardiovasc Surg 67, 44–52 (2019). https://doi.org/10.1007/s11748-017-0839-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-017-0839-0

Keywords

Search

Navigation